Acetaminophen Oral Solution Recalled for Manufacturing Process Control Failures
Plastikon Healthcare LLC is recalling acetaminophen oral solution (650 mg per 20.3 mL cup) distributed nationwide due to manufacturing process control failures.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with manufacturing control failures represents a risk-of-harm situation where injury has not yet been reported. Per the rubric, when no illnesses or injuries are documented and the hazard is theoretical, the score is at most 3.
Plain-English summary
Plastikon Healthcare LLC is recalling Acetaminophen Oral Solution 650 mg per 20.3 mL cup distributed nationwide in the United States. The recall is due to manufacturing process control failures, as the products were manufactured under conditions that did not adequately maintain required manufacturing controls.
Approximately 3,507,740 cups are affected by this recall. The product is packaged 10 cups per tray and 10 trays per carton, for institutional use only. Affected lot numbers include 20064A, 20066A, and others, with expiration dates ranging from June 2022 through March 2024. The product is identified by NDC number 0904-6820-76.
This is a Class II recall, indicating the FDA considers there to be potential for serious adverse health consequences, though no illnesses or injuries have been reported. Individuals who have used this product should consult their healthcare provider if they have concerns.
The recalled product
- Product
- Acetaminophen Oral Solution 650 mg / 20.3 mL, 20.3 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr. Suite 233, Livonia, MI 48152, NDC 0904-6820-76
- Manufacturer
- Plastikon Healthcare LLC
- Category
- Drug
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 20064A
- 20066A
- EXP Jun. 2022
- 20069A
- 20073A
- EXP Jul. 2022
- 20094A
- 20094B
- 20095A
- 20095B
- EXP Sep. 2022
- 20103A
- EXP Oct. 2022
- 20105A
- EXP Nov. 2022
- 20111A
- 20111B
- EXP Dec. 2022
- 21005A
- 21005B
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01